To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

September 09, 2019___

Today's Rundown

Featured Story

Amgen's KRAS drug continues to deliver but faces 'curse' of high expectations

Amgen unveiled data for the highest dose of its KRAS inhibitor, showing it kept cancer at bay in 100% of lung cancer patients and shrank tumors in more than half of them. Though the data were impressive, Amgen's stock dipped in premarket trading.

Top Stories

Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer

BARCELONA—Now within the ownership of Eli Lilly, Loxo Oncology has presented new data at the World Conference on Lung Cancer for its RET inhibitor LOXO-292 as it plots an NDA in the coming months.

Pfizer spinout Cerevel hires Coles as CEO

Tony Coles has taken up the CEO role at Pfizer spinout Cerevel Therapeutics. The appointment puts the man who led Onyx to a $10 billion takeover in charge of using $350 million of Bain Capital’s money to advance a pipeline of neuroscience programs. 

[Sponsored] What Makes an Oncology Clinical Trial Site Stand Out from the Competition?

Patients want the best cancer therapies, and sites that enable clinical trials are the ones that can access those new drugs faster. Here’s how

Ito out at PureTech, MIT after Epstein funding scandal exposed

Joichi Ito has been forced out as head of the Media Lab at MIT as well as from biotech builder PureTech’s board after financial ties to the deceased sex offender Jeffrey Epstein were uncovered.

Ayala Pharma nabs AbbVie cancer exec Gordon as CMO

Ayala Pharmaceuticals has hired AbbVie’s former vice president of oncology Gary Gordon, M.D., Ph.D., as its new chief medical officer.

Swiss biotech ADC Therapeutics guns for $150M IPO

After a bumper series of private funding rounds, cancer biotech ADC Therapeutics is now looking to go public with a $150 million NYSE IPO attempt.

4BIO raises VC fund to take cell and gene therapies mainstream

4BIO Capital plans to pump $50 million (€45 million), plus another $100 million it hopes to add by the final close, into companies that are working to extend use of advanced therapies to major diseases such as diabetes and rheumatoid arthritis.

New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more

Although psychedelic drugs have shown promise in the treatment of multiple diseases, research into these compounds has been stymied. Johns Hopkins is trying to remedy that with a new, privately funded center for psychedelic research.

WCLC: AstraZeneca heads for Roche battle with Imfinzi small-cell survival win

Right now, Roche’s Tecentriq is the only immuno-oncology therapy approved in small cell lung cancer, but AstraZeneca’s Imfinzi added to standard-of-care chemo reduced newly diagnosed extensive-stage patients’ risk of death by 27% in a phase 3 study.

Enrollment Showcase

BioImmersion: Biotech for the Non-Scientist

BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today!

Resources

[Whitepaper] How Can You Avoid the Fallout From Incompatibility Between Your API and Its Formulation?

Avoid potential risks to the patient as well as costly interruptions during development.

[Article] Why Market Leaders Outsource IT Requirements For A Competitive Edge

Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage.

[Whitepaper] From Complex to Controlled: Advanced Data Management Strategies for Advanced Therapies

Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success.

[Whitepaper] Advancing Healthcare Market Intelligence With Smart Search Technology

AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy.

[Whitepaper] What's Your Lab Trying to Tell You? Listen with Connected IoT Sensors

Your lab is talking to you, are you listening?

[Whitepaper] Prevent the Real World From Derailing Your Clinical Trial: Focus on Protocol Design

Want to be sure your renal research protocol design is fit for the real world?

[Whitepaper] Optimizing Operations in Multiproduct Pharma Manufacturing Facilities

Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities?

[Report] Future of clinical trials: From real-time data to algorithmic trials

Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours.

[Whitepaper] Considerations and Options for Prefilled Syringes

Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe.

[Article] Sales Compensation: 7 Trending Topics

From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation.

[Whitepaper] Enhancing Productivity in Drug Discovery: Removing Inefficiencies and Distractions Caused by Chemicals and Biologics Management

The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D.

[Whitepaper] The Supply Chain Planning Cure for Everything from Product Expirations to Patent Cliffs

Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events